Kuwano; Mitsuaki
Patent Applications and Registrations
Patent applications and USPTO patent grants for Kuwano; Mitsuaki.The latest application filed is for "ophthalmic solution comprising diquafosol".
- Kuwano; Mitsuaki - Osaka JP
- Kuwano; Mitsuaki - Osaka-shi Osaka JP
- Kuwano; Mitsuaki - Osaka-shi JP
- Kuwano; Mitsuaki - Ikoma JP
- Kuwano; Mitsuaki - Nara JP
- Kuwano; Mitsuaki - Ikoma-shi JP
- Kuwano; Mitsuaki - Toyonaka JP
| Patent | Date |
|---|---|
| Ophthalmic solution comprising Diquafosol Grant 11,166,974 - Sakatani , et al. November 9, 2 | 2021-11-09 |
| Ophthalmic Solution Comprising Diquafosol App 20200215093 - Sakatani; Akiko ; et al. | 2020-07-09 |
| Ophthalmic solution comprising diquafosol Grant 10,632,139 - Sakatani , et al. | 2020-04-28 |
| Ophthalmic Solutions App 20180353518 - Morishima; Kenji ; et al. | 2018-12-13 |
| Ophthalmic Solution Comprising Diquafosol App 20180353531 - Sakatani; Akiko ; et al. | 2018-12-13 |
| Ophthalmic solution comprising diquafosol Grant 10,071,113 - Sakatani , et al. September 11, 2 | 2018-09-11 |
| Ophthalmic Solution Comprising Diquafosol App 20170020910 - SAKATANI; Akiko ; et al. | 2017-01-26 |
| Ophthalmic solution comprising diquafosol Grant 9,486,529 - Sakatani , et al. November 8, 2 | 2016-11-08 |
| Ophthalmic Solutions App 20160106757 - MORISHIMA; Kenji ; et al. | 2016-04-21 |
| Ophthalmic Solution Comprising Diquafosol App 20150072951 - Sakatani; Akiko ; et al. | 2015-03-12 |
| Ophthalmic Solution Comprising Diquafosol, Method For Producing The Same, And Method For Inhibiting Formation Of Insoluble Precipitate App 20140221306 - Sakatani; Akiko ; et al. | 2014-08-07 |
| Process for producing microparticles Grant 7,923,034 - Yamada , et al. April 12, 2 | 2011-04-12 |
| Delivering substance and drug delivery system using the same Grant 7,455,855 - Kuwano , et al. November 25, 2 | 2008-11-25 |
| Eyedrops containing particulate agar App 20080199524 - Inohara; Masahiro ; et al. | 2008-08-21 |
| Opthalmic solutions App 20070248697 - Morishima; Kenji ; et al. | 2007-10-25 |
| Drug delivery system using subconjunctival depot App 20060039979 - Yamada; Kazuhito ; et al. | 2006-02-23 |
| Drug delivery system using subconjunctival depot App 20060013859 - Yamada; Kazuhito ; et al. | 2006-01-19 |
| Drug delivery system for the subconjunctival administration of fine grains App 20050089545 - Kuwano, Mitsuaki ; et al. | 2005-04-28 |
| Polysaccharide-containing compositions and use thereof App 20040266725 - Inohara, Masahiro ; et al. | 2004-12-30 |
| Injections for eye tissues containing drug bonded to polyethlene glycol App 20040254197 - Tasaka, Humitaka ; et al. | 2004-12-16 |
| Eye drops App 20040097592 - Morishima, Kenji ; et al. | 2004-05-20 |
| Remedies for keratoconjunctival diseases containing farnesyl acetate as the active ingredient App 20040014812 - Nakata, Katsuhiko ; et al. | 2004-01-22 |
| Transporters and drug delivery system using the same App 20030144247 - Kuwano, Mitsuaki ; et al. | 2003-07-31 |
| Cyclosporin compositions Grant 6,582,718 - Kawashima , et al. June 24, 2 | 2003-06-24 |
| Ophthalmic compositions App 20020045601 - Kawashima, Yoichi ; et al. | 2002-04-18 |
| Ophthalmic compositions Grant 5,951,971 - Kawashima , et al. September 14, 1 | 1999-09-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 